BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16935614)

  • 1. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma.
    Hirooka K; Baba T; Fujimura T; Shiraga F
    Am J Ophthalmol; 2006 Sep; 142(3):523-5. PubMed ID: 16935614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of asymmetric visual field defects in normal-tension and high-tension glaucoma.
    Poinoosawmy D; Fontana L; Wu JX; Bunce CV; Hitchings RA
    Ophthalmology; 1998 Jun; 105(6):988-91. PubMed ID: 9627646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E
    Ophthalmology; 2003 Feb; 110(2):359-62; discussion 362-4. PubMed ID: 12578781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure.
    Koseki N; Araie M; Yamagami J; Shirato S; Yamamoto S
    J Glaucoma; 1999 Apr; 8(2):117-23. PubMed ID: 10209728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes.
    Koseki N; Araie M; Suzuki Y; Yamagami J
    Jpn J Ophthalmol; 1995; 39(3):274-83. PubMed ID: 8577079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma.
    Tokunaga T; Kashiwagi K; Tsumura T; Taguchi K; Tsukahara S
    Jpn J Ophthalmol; 2004; 48(4):380-5. PubMed ID: 15295667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects.
    Piltz JR; Bose S; Lanchoney D
    J Glaucoma; 1998 Oct; 7(5):336-42. PubMed ID: 9786563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal fluctuation and concordance of intraocular pressure in glaucoma suspects and normal tension glaucoma patients.
    Shuba LM; Doan AP; Maley MK; Zimmerman MB; Dinn RB; Greenlee EC; Alward WL; Kwon YH
    J Glaucoma; 2007 May; 16(3):307-12. PubMed ID: 17438425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of central visual field in end-stage glaucoma.
    Much JW; Liu C; Piltz-Seymour JR
    Ophthalmology; 2008 Jul; 115(7):1162-6. PubMed ID: 18067965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma.
    Inatani M; Iwao K; Inoue T; Awai M; Muto T; Koga T; Ogata-Iwao M; Hara R; Futa R; Tanihara H
    J Glaucoma; 2008; 17(4):275-9. PubMed ID: 18552612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of localized retinal nerve fiber layer defects between a low-teen intraocular pressure group and a high-teen intraocular pressure group in normal-tension glaucoma patients.
    Kim DM; Seo JH; Kim SH; Hwang SS
    J Glaucoma; 2007 May; 16(3):293-6. PubMed ID: 17438422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients.
    Cho HK; Kee C
    Am J Ophthalmol; 2012 Dec; 154(6):958-968.e1. PubMed ID: 22959361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes.
    Fogagnolo P; McNaught A; Centofanti M; Rossetti L; Orzalesi N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4557-63. PubMed ID: 17898278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field damage in normal-tension glaucoma patients with or without ischemic changes in cerebral magnetic resonance imaging.
    Suzuki J; Tomidokoro A; Araie M; Tomita G; Yamagami J; Okubo T; Masumoto T
    Jpn J Ophthalmol; 2004; 48(4):340-4. PubMed ID: 15295658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the extent of myopia on the progression of normal-tension glaucoma.
    Sohn SW; Song JS; Kee C
    Am J Ophthalmol; 2010 May; 149(5):831-8. PubMed ID: 20231010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.